Protein chips for infectious disease serology and pathogen proteome characterization have become increasingly important research and diagnostic tools, with the US Protein Chip Market reflecting the COVID-19-driven acceleration of multiplexed serology platforms and the broader applications of pathogen proteome arrays for diagnostics, vaccine development, and immune response characterization.

SARS-CoV-2 antigen microarrays — displaying multiple viral spike, nucleocapsid, and accessory protein antigens to characterize the antibody response breadth following infection versus vaccination — provided research tools distinguishing infection-induced from vaccine-induced immunity during the COVID-19 pandemic. The differential antigen recognition patterns — with vaccination inducing spike-focused antibody responses while infection inducing broader multi-antigen responses — enabled serostatus discrimination that single-antigen serology could not achieve.

Pathogen proteome arrays — displaying the complete expressed protein repertoire of bacterial and viral pathogens — enable comprehensive mapping of the human antibody response to infection for vaccine target identification. The complete H. pylori, Borrelia burgdorferi (Lyme disease), and HIV proteome arrays have identified immunodominant antigens and novel diagnostic markers that targeted antigen approaches would not discover without the comprehensive proteome display that full proteome arrays provide.

Multiplex respiratory virus serology — simultaneously measuring antibodies against multiple respiratory viruses including influenza A and B subtypes, RSV, parainfluenza, and SARS-CoV-2 from a single serum sample — provides epidemiological surveillance capability that enables population-level respiratory virus immunity mapping studies that sequential single-virus serology testing cannot practically accomplish.

Do you think pathogen proteome arrays will become standard tools in pandemic preparedness programs for rapid characterization of immune responses to novel pathogens?

FAQ

What are pathogen proteome arrays? Pathogen proteome arrays display the complete expressed protein repertoire of a pathogen on a microarray surface, enabling comprehensive mapping of human antibody responses to identify diagnostic markers, vaccine targets, and immune response correlates of protection.

How were protein arrays used in COVID-19 research? SARS-CoV-2 antigen microarrays characterized the breadth and specificity of antibody responses to infection versus vaccination, identified cross-reactive antibodies recognizing related coronaviruses, and enabled epidemiological serosurveillance studies of population immunity.

#USProteinChip #InfectiousDiseaseArray #COVID19Serology #PathogenProteome #VaccineResearch #EpidemiologyArrays